2020 Presentations & reports – Zelira Therapeutics

Proactive – Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

December 18, 2020

Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Proactive – Zelira Therapeutics and Emyria team up for ‘disruptive’ autism spectrum disorder trial

November 9, 2020

Some excerpt

Investor Presentation – Non-Deal Roadshow

Investor Presentation – Non-Deal Roadshow

October 22, 2020

ASX Small and Mid-Cap Conference

ASX Small and Mid-Cap Conference

October 9, 2020

Presentation – ASX Small and Mid-Cap Conference

Proactive – ASX Small and Mid-Cap Conference

September 9, 2020

Proactive – CEO Investor Sessions

August 11, 2020

Investor Presentation

Investor Presentation

Investor Presentation – Logistics for Benzinga conference

Investor Presentation – Logistics for Benzinga conference

Investor Presentation – Non-deal Roadshow

Investor Presentation – Non-deal Roadshow

Insomnia Phase 2 Clinical Trial Presentation

Insomnia Phase 2 Clinical Trial Presentation

1
2